Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Secures $7.3M Deal for Camillus Solar Project

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., has announced the sale and related construction contract for the 3.26 MW Camillus Solar Project for Solar Advocate […]

DGE’s 5th PRC Performance Optimization Summit in Philadelphia to Cover all Aspects of Promotional Review

The 5th PRC Performance Optimization Summit by DGE will be held in Philadelphia on April 29-30, 2025. DGE invites industry professionals to discuss compliance and the expertise needed to get the best regulatory results for advertising/promotional material. The summit is hosted by Dynamic Global Events (“DGE”), a pioneer in organizing B2B events for life science […]

FAVO Capital Inc. (FAVO) Strengthening Position in Growing Private Credit, Alternative Lending Markets

The financial landscape is rapidly evolving, with private credit and alternative lending markets emerging as key drivers of growth and innovation. As traditional banking institutions tighten their lending criteria and businesses seek more flexible financing solutions, the demand for alternative lending options, such as FAVO Capital (OTC: FAVO), continues to soar. This shift is fueling […]

Investors Brace for a New Era of Venture Debt: Navigating Complex Risks and Strategies Ahead of April’s Venture Debt Conference

As venture debt enters a pivotal phase in 2025, investors are faced with a more complex and volatile lending environment. The shifting dynamics, influenced by rising interest rates and the unprecedented collapse of Silicon Valley Bank, demand a much more sophisticated approach to risk management. While venture debt continues to serve as an essential source […]

Alt Products Expo Concludes in Medellín, Sets Sights on Miami in April

The Alternative Products Expo successfully wrapped up its 2025 event in Medellín, Colombia, on March 1-2, reinforcing its position as a premier gathering for the counterculture industry. This year’s event brought together thousands of attendees, including leading manufacturers, retailers, wholesalers, entrepreneurs, and industry pioneers, to explore innovations, foster connections, and capitalize on emerging market opportunities. […]

Adageis Simplifies Value-Based Care for Healthcare Providers

Healthcare providers often struggle with complex reimbursement structures, making it difficult to optimize cash flow while ensuring high-quality value-based patient care. Adageis is a forward-thinking healthcare technology company reshaping patient care through flexible AI-centric software solutions for healthcare organizations. The company is able to simplify this process with its AI-powered ProActive Care Platform, a fintech […]

Brera Holdings PLC (NASDAQ: BREA) Building Grassroots Football Opportunities for Young Athletes

Brera Holdings (NASDAQ: BREA), an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) approach, is committed to supporting grassroots football and expanding opportunities for young athletes, with the Juve Stabia Academy being a prime example. This initiative looks to tap into talent […]

 

From Our Blog

VERAXA Biotech AG (NASDAQ: VRXA) Advances BiTAC-ADC Platform as It Expands Next-Generation Cancer Therapy Pipeline

June 24, 2026

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has announced new in vitro proof-of-concept data supporting its BiTAC-ADC platform, a technology designed to improve the selectivity of antibody-drug conjugates in cancer treatment. The announcement comes as the company prepares to engage with potential pharmaceutical and biotechnology partners during the BIO International […]

Rotate your device 90° to view site.